Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Cancer

MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation

E. H. Allott; J. Lysaght; M. C. Cathcart; C. L. Donohoe; R. Cummins; S. A. McGarrigle; E. Kay; J. V. Reynolds; G. P. Pidgeon MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation Mol Carcinog
Genetics

Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis

E. H. Allott; M. J. Morine; J. Lysaght; S. A. McGarrigle; C. L. Donohoe; J. V. Reynolds; H. M. Roche; G. P. Pidgeon Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis Clin Transl Gastroenterol

Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke

D. O'Shea; T. J. Cawood; C. O'Farrelly; L. Lynch Natural killer cells in obesity: impaired function and increased susceptibility to the effects of cigarette smoke PLoS One

Dysregulation of Natural Killer Cells in Obesity

D. O'Shea; A. E. Hogan Dysregulation of Natural Killer Cells in Obesity Cancers (Basel)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans

W. Naujoks; D. Quandt; A. Hauffe; H. Kielstein; I. Bähr; J. Spielmann Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans Front Immunol

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses

X. Michelet; L. Dyck; A. Hogan; R. M. Loftus; D. Duquette; K. Wei; S. Beyaz; A. Tavakkoli; C. Foley; R. Donnelly; C. O'Farrelly; M. Raverdeau; A. Vernon; W. Pettee; D. O'Shea; B. S. Nikolajczyk; K. H. G. Mills; M. B. Brenner; D. Finlay; L. Lynch Metabolic reprogramming of natural killer cells in obesity limits antitumor responses Nat Immunol

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity

L. Lynch; D. O'Shea; D. C. Winter; J. Geoghegan; D. G. Doherty; C. O'Farrelly Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity Eur J Immunol

Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial

J. M. Groarke; J. Richmond; J. Mc Sharry; A. Groarke; O. M. Harney; M. G. Kelly; J. C. Walsh Acceptability of a Mobile Health Behavior Change Intervention for Cancer Survivors With Obesity or Overweight: Nested Mixed Methods Study Within a Randomized Controlled Trial JMIR Mhealth Uhealth

Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

E. Molina-Montes; C. Coscia; P. Gómez-Rubio; A. Fernández; R. Boenink; M. Rava; M. Márquez; X. Molero; M. Löhr; L. Sharp; C. W. Michalski; A. Farré; J. Perea; M. O'Rorke; W. Greenhalf; M. Iglesias; A. Tardón; T. M. Gress; V. M. Barberá; T. Crnogorac-Jurce Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses Gut
Insulin Resistance & Diabetes

Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data

J. A. Rothwell; M. Jenab; M. Karimi; T. Truong; Y. Mahamat-Saleh; P. Ferrari; S. G. Dashti; T. Kühn; A. J. Cross; G. Severi; M. J. Gunter; N. Murphy Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data Clinical Gastroenterology and Hepatology
Metabolic Syndrome

Older posts

Newer posts

← Previous Page1 … Page3 Page4 Page5 … Page10 Next →

Search for:

Recent Posts

Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI